The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Kilitch Drugs India Ltd

Kilitch Drugs India Ltd

BSE 524500 · NSE KILITCH · ISIN INE729D01010 · Group T · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹171.95

-0.20%

BSE close, 28 August 2026

Market cap

₹601.16 cr

3.5 cr shares · Micro cap

Free float

₹204.01 cr

as published

P/E · P/B

18.4× · 2.54×

EPS ₹9.34 · BV ₹67.70

FY25-26 rev / PAT

188.57 / 32.40

₹ cr, as filed

Filings, window

11

2 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹121.10 52-WK HIGH ₹219.68 ₹171.95 52% of range
Against 52-week high-21.7%
Against 52-week low+42.0%
Day change-0.20%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹9.34
Price / earnings18.41×
Price / book2.54×
Book value — derived, price ÷ P/B₹67.70
Return on equity13.79%
Operating margin20.03%
Net margin12.35%

Consistency check

P/B ÷ P/E, which must equal ROE
13.80%
ROE as published
13.79%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 40.91 5.05 1.45 20.03% 12.35%
Mar-26 · Q 71.97 14.00 4.08 28.63% 19.45%
FY25-26 188.57 32.40 9.57 24.54% 17.18%

Quarter on quarter

Revenue, quarter on quarter
-43.2%
Net profit, quarter on quarter
-63.9%
Operating margin, quarter on quarter
-860 bps

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM2
Newspaper Publication2
Board Meeting1
Compliance Certificate1
Monitoring Agency1
Outcome1
Trading Window1
Procedural sub-total9
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 2 selected · busiest 2026-08-13 and 2026-08-18

Filing rhythm · the twelve most recent

2026-07-282026-10-08

SelectedProcedural

Filings

11 in the window · 3 earlier on record

  1. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    We are submitting herewith the certificate under regulation 74(5) of SEBI DP regulations

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    We are submitting herewith the intimation of closure of trading window

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 27 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    We are submitting herewith the scrutinizer's report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited

    AGM/EGM / AGM View filing →

  4. 27 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    We are submitting herewith the proceeding of 34th Annual General Meeting

    AGM/EGM / AGM View filing →

  5. 18 August 2026 ·

    Monitoring Agency

    Monitoring Agency Report

    We are submitting herewith the monitoring agency report

    Company Update / Monitoring Agency Report View filing →

  6. 18 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026

    Company Update / Newspaper Publication View filing →

  7. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Financial Results For The Quarter Ended 30Th June 2026

    Submission of financial results for the quarter ended 30th June 2026

    Board Meeting / Outcome of Board Meeting View filing →

  8. 13 August 2026 ·

    Results

    Financial Results For The Quarter Ended 30Th June 2026

    We are submitting herewith the financial results for the quarter ended 30th June 2026

    Result / Financial Results View filing →

  9. 10 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2026

    Kilitch Drugs India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve unaudited standalone and ....

    Board Meeting / Board Meeting View filing →

  10. 4 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    We are submitting herewith the copy of the newspaper publication of extract of AGM Notice

    Company Update / Newspaper Publication View filing →

  11. 28 July 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of board meeting is enclosed for ready reference

    Others / Outcome without intimation View filing →

RSS feed for Kilitch Drugs India Ltd · the 50 most recent filings